Selectively removing S100A4-expressing cells was able to sufficiently block tumor growth both in vitro and in vivo; and meanwhile, S100A4 is also identified as a critical regulator of glioma stem cells self-renewal both in mouse and patient-derived glioma tumorspheres in this research. The gene discussed is S100A4; the disease is central nervous system cancer.